Anaplastic lymphoma kinase-positive large B-cell lymphoma: Description of a case with an unexpected clinical outcome

Magda Zanelli, Riccardo Valli, Isabella Capodanno, Moira Ragazzi, Stefano Ascani

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Anaplastic lymphoma kinase-positive (ALK-positive) large B-cell lymphoma is a rare and aggressive variant of large B-cell lymphoma (LBCL), first reported by Delsol et al in 1997, showing distinctive morphologic, immunophenotypic and cytogenetic features. The latest 2008 World Health Organization Classification of Tumours of Haematopoietic and Lymphoid tissues recognizes ALK-positive LBCL as a separate entity. Here, we report a case of ALK-positive large B-cell lymphoma in a 53-year-old man with diffuse abdominal and mediastinal lymph-nodes involvement. According to the Ann Arbor staging system, the patient had a stage IIIB lymphoma. The age-adjusted International Prognostic Index was 2 (stage III and elevated lactate dehydrogenase), so the disease was considered high risk. The patient underwent chemotherapy, radiotherapy, and an autologous stem cell transplantation. The patient is alive and free of disease 35 months after diagnosis.

Original languageEnglish
Pages (from-to)78-83
Number of pages6
JournalInternational Journal of Surgical Pathology
Volume23
Issue number1
DOIs
Publication statusPublished - Feb 13 2015

Fingerprint

B-Cell Lymphoma
Stem Cell Transplantation
Lymphoid Tissue
L-Lactate Dehydrogenase
Cytogenetics
Lymphoma
Radiotherapy
Lymph Nodes
Drug Therapy
anaplastic lymphoma kinase
Neoplasms

Keywords

  • ALK positivity
  • ALK-positive large B-cell lymphoma
  • Anaplastic lymphoma kinase (ALK)
  • Immunohistochemistry
  • Large B-cell lymphoma
  • t(2; 17)

ASJC Scopus subject areas

  • Anatomy
  • Pathology and Forensic Medicine
  • Surgery
  • Medicine(all)

Cite this

Anaplastic lymphoma kinase-positive large B-cell lymphoma : Description of a case with an unexpected clinical outcome. / Zanelli, Magda; Valli, Riccardo; Capodanno, Isabella; Ragazzi, Moira; Ascani, Stefano.

In: International Journal of Surgical Pathology, Vol. 23, No. 1, 13.02.2015, p. 78-83.

Research output: Contribution to journalArticle

@article{6cfedcb7ddb74035945c9f24749303e3,
title = "Anaplastic lymphoma kinase-positive large B-cell lymphoma: Description of a case with an unexpected clinical outcome",
abstract = "Anaplastic lymphoma kinase-positive (ALK-positive) large B-cell lymphoma is a rare and aggressive variant of large B-cell lymphoma (LBCL), first reported by Delsol et al in 1997, showing distinctive morphologic, immunophenotypic and cytogenetic features. The latest 2008 World Health Organization Classification of Tumours of Haematopoietic and Lymphoid tissues recognizes ALK-positive LBCL as a separate entity. Here, we report a case of ALK-positive large B-cell lymphoma in a 53-year-old man with diffuse abdominal and mediastinal lymph-nodes involvement. According to the Ann Arbor staging system, the patient had a stage IIIB lymphoma. The age-adjusted International Prognostic Index was 2 (stage III and elevated lactate dehydrogenase), so the disease was considered high risk. The patient underwent chemotherapy, radiotherapy, and an autologous stem cell transplantation. The patient is alive and free of disease 35 months after diagnosis.",
keywords = "ALK positivity, ALK-positive large B-cell lymphoma, Anaplastic lymphoma kinase (ALK), Immunohistochemistry, Large B-cell lymphoma, t(2; 17)",
author = "Magda Zanelli and Riccardo Valli and Isabella Capodanno and Moira Ragazzi and Stefano Ascani",
year = "2015",
month = "2",
day = "13",
doi = "10.1177/1066896914536223",
language = "English",
volume = "23",
pages = "78--83",
journal = "International Journal of Surgical Pathology",
issn = "1066-8969",
publisher = "SAGE Publications Inc.",
number = "1",

}

TY - JOUR

T1 - Anaplastic lymphoma kinase-positive large B-cell lymphoma

T2 - Description of a case with an unexpected clinical outcome

AU - Zanelli, Magda

AU - Valli, Riccardo

AU - Capodanno, Isabella

AU - Ragazzi, Moira

AU - Ascani, Stefano

PY - 2015/2/13

Y1 - 2015/2/13

N2 - Anaplastic lymphoma kinase-positive (ALK-positive) large B-cell lymphoma is a rare and aggressive variant of large B-cell lymphoma (LBCL), first reported by Delsol et al in 1997, showing distinctive morphologic, immunophenotypic and cytogenetic features. The latest 2008 World Health Organization Classification of Tumours of Haematopoietic and Lymphoid tissues recognizes ALK-positive LBCL as a separate entity. Here, we report a case of ALK-positive large B-cell lymphoma in a 53-year-old man with diffuse abdominal and mediastinal lymph-nodes involvement. According to the Ann Arbor staging system, the patient had a stage IIIB lymphoma. The age-adjusted International Prognostic Index was 2 (stage III and elevated lactate dehydrogenase), so the disease was considered high risk. The patient underwent chemotherapy, radiotherapy, and an autologous stem cell transplantation. The patient is alive and free of disease 35 months after diagnosis.

AB - Anaplastic lymphoma kinase-positive (ALK-positive) large B-cell lymphoma is a rare and aggressive variant of large B-cell lymphoma (LBCL), first reported by Delsol et al in 1997, showing distinctive morphologic, immunophenotypic and cytogenetic features. The latest 2008 World Health Organization Classification of Tumours of Haematopoietic and Lymphoid tissues recognizes ALK-positive LBCL as a separate entity. Here, we report a case of ALK-positive large B-cell lymphoma in a 53-year-old man with diffuse abdominal and mediastinal lymph-nodes involvement. According to the Ann Arbor staging system, the patient had a stage IIIB lymphoma. The age-adjusted International Prognostic Index was 2 (stage III and elevated lactate dehydrogenase), so the disease was considered high risk. The patient underwent chemotherapy, radiotherapy, and an autologous stem cell transplantation. The patient is alive and free of disease 35 months after diagnosis.

KW - ALK positivity

KW - ALK-positive large B-cell lymphoma

KW - Anaplastic lymphoma kinase (ALK)

KW - Immunohistochemistry

KW - Large B-cell lymphoma

KW - t(2; 17)

UR - http://www.scopus.com/inward/record.url?scp=84920859569&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920859569&partnerID=8YFLogxK

U2 - 10.1177/1066896914536223

DO - 10.1177/1066896914536223

M3 - Article

C2 - 24868005

AN - SCOPUS:84920859569

VL - 23

SP - 78

EP - 83

JO - International Journal of Surgical Pathology

JF - International Journal of Surgical Pathology

SN - 1066-8969

IS - 1

ER -